AmerisourceBergan has warned of the dangers of reimportation a day after the Senate rejected Bernie Sanders’ “Trump proposal” to overturn the ban.
Recipharm has entered into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary.
Swedish Orphan Biovitrum AB (Sobi) and Horizon Pharma plc have teamed up for a 5-year deal to distribute urea cycle disorder drugs Ravicti and Ammonaps in Europe and the Middle East.
Fareva Group has set up an aerosol manufacturing facility at its site in Richmond, Virginia as part of a $40m (€37m) investment in its drug, OTC medicine and beauty care business.
Acticor Biotech has made a deal with Merck KGaA’s CMO MilliporeSigma to use its Provantage End-to-End services to make its anti-thrombotic antibody fragment ACT-017 for stroke.
Almac Clinical Technologies, part of the Almac Group, has announced a strategic partnership with the contract research organization (CRO) inVentiv Health.
Content Provided by Reading Scientific Services Ltd.
Sometimes it's the smallest details that have the biggest impact on pharmaceutical performance. That's certainly true when it comes down to the properties of particles and their impact on pharmaceutical performance. Subtle changes in particle size, shape and distribution can have a major impact on pharmaceutical solubility, stability and efficacy.
Content Provided by World Courier
Southeast Asia is a growing pharmaceutical market, with a population of 620 million. What opportunities are there for multinational companies to access this rich area?